Literature DB >> 31575303

Late preterm: a new high risk group in neonatology.

Deepak Sharma1, Inumarthi Vara Padmavathi2, Seyed Ahmad Tabatabaii3, Nazanin Farahbakhsh4.   

Abstract

Late preterm infants are those infants born between 34 0/7 weeks through 36 6/7 week of gestation. These are physiologically less mature and have limited compensatory responses to the extrauterine environment compared with term infants. Despite their increased risk for morbidity and mortality, late preterm newborns are often cared in the well-baby nurseries of hospital after birth and are discharged from the hospital by 2-3 days of postnatal age. They are usually treated like developmentally mature term infants because many of them are of same birth weight and same size as term infants. There is a steady increase in the late preterm birth rate in last decade because of either maternal, fetal, or placental/uterine causes. There has been shift in the distribution of births from term and post-term toward earlier gestations. Although late preterm infants are the largest subgroup of preterm infants, there has been little research on this group until recently. This is mainly because of labeling them as "near-term". Such infants were being looked upon as "almost mature", and were thought as neonate requiring either no or minimal concern. In the obstetric and pediatric practice, late preterm infants are often considered functionally and developmentally mature and often managed by protocols developed for full-term infants. Thus, limited efforts are taken to prolong pregnancy in cases of preterm labor beyond 34 weeks, moreover after 34 weeks most centers do not administer antenatal prophylactic steroids. These practices are based on previous studies reporting neonatal mortality and morbidity in the late preterm period to be only slightly higher in comparison with term infants and whereas in the current scenario the difference is significant. Late preterm infants have 2-3-fold increased risk of morbidities such as hypothermia, hypoglycemia, delayed lung fluid clearance, respiratory distress, poor feeding, jaundice, sepsis, and readmission rates after initial hospital discharge. This leads to huge impact on the overall health care resources. In this review, we cover various aspects of these late preterm infants like etiology, immediate and long-term outcome.

Entities:  

Keywords:  Late preterm; morbidities; mortality

Mesh:

Year:  2019        PMID: 31575303     DOI: 10.1080/14767058.2019.1670796

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  5 in total

1.  Urine podocyte mRNA loss in preterm infants and related perinatal risk factors.

Authors:  Qi Gao; Congchao Lu; Xiuying Tian; Jun Zheng; Fangrui Ding
Journal:  Pediatr Nephrol       Date:  2022-06-27       Impact factor: 3.714

2.  Nutritional Management of Moderate- and Late-Preterm Infants Commenced on Intravenous Fluids Pending Mother's Own Milk: Cohort Analysis From the DIAMOND Trial.

Authors:  Tanith Alexander; Michael Meyer; Jane E Harding; Jane M Alsweiler; Yannan Jiang; Clare Wall; Mariana Muelbert; Frank H Bloomfield
Journal:  Front Pediatr       Date:  2022-03-31       Impact factor: 3.418

3.  Gestational Diabetes Melitus and Cord Blood Platelet Function Studied via the PFA-100 System.

Authors:  Vasiliki Mougiou; Theodora Boutsikou; Rozeta Sokou; Maria Kollia; Serena Valsami; Abraham Pouliakis; Maria Boutsikou; Marianna Politou; Nicoletta Iacovidou; Zoe Iliodromiti
Journal:  Diagnostics (Basel)       Date:  2022-07-06

4.  Sleep problems in preschool children at the child development center with different developmental status: A questionnaire survey.

Authors:  Chi-Man Kuok; Jia-Rou Liu; Jao-Shwann Liang; Shao-Han Chang; Ming-Tao Yang
Journal:  Front Pediatr       Date:  2022-09-14       Impact factor: 3.569

5.  Long-term predictivity of early neurological assessment and developmental trajectories in low-risk preterm infants.

Authors:  Daniela Dicanio; Giulia Spoto; Angela Alibrandi; Roberta Minutoli; Antonio Gennaro Nicotera; Gabriella Di Rosa
Journal:  Front Neurol       Date:  2022-09-27       Impact factor: 4.086

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.